Callan Family Office, LLC Standard Biotools Inc. Transaction History
Callan Family Office, LLC
- $3.17 Trillion
- Q2 2025
A detailed history of Callan Family Office, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Callan Family Office, LLC holds 11,875 shares of LAB stock, worth $15,556. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,875Holding current value
$15,556% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LAB
# of Institutions
158Shares Held
278MCall Options Held
6KPut Options Held
36.6K-
Casdin Capital, LLC New York, NY76.1MShares$99.7 Million9.61% of portfolio
-
Viking Global Investors LP58.7MShares$76.8 Million0.21% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$28.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$22.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY10.7MShares$14 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $103M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...